日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased Endothelin-1 and High-Risk APOL1 Variants Contribute to Albuminuria in Pediatric and Young Adults with Sickle Cell Anemia

内皮素-1 水平升高和高危 APOL1 变异体是镰状细胞贫血症患儿和青少年出现蛋白尿的原因。

Kasztan, Malgorzata; Kang, Guolian; Botta, Davide; Pollock, David M; Rashkin, Sara; Zahr, Rima; Lebensburger, Jeffrey

Rethinking Sickle Cell Disease as a Systemic Vasculopathy

重新思考镰状细胞病作为一种系统性血管病

DuPont, Mariana; Galadanci, Najibah A; Patel, Rushil V; Lebensburger, Jeffrey; Kanter, Julie

Relation of sleep quality, sleep disturbance, and hydroxyurea use to neurocognitive function in youth living with sickle cell disease

睡眠质量、睡眠障碍和羟基脲使用与镰状细胞病青少年神经认知功能的关系

Tucker, Tiffany D; Reddy, Karthik; Alishlash, Ammar S; Mrug, Sylvie; Lebensburger, Jeffrey D; Thomas, Justin S; Guest, Kristi C; Murdaugh, Donna L

Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia

镰状细胞贫血症儿童和成人持续性蛋白尿多基因风险评分的开发

Zahr, Rima S; Kang, Guolian; Zhang, Xu; Rashkin, Sara R; Kovesdy, Csaba P; Takemoto, Clifford; Weiss, Mitch; Lebensburger, Jeffrey; Ataga, Kenneth I; Saraf, Santosh L

Emergency department intravenous fluid resuscitation and renal outcomes among adults with sickle cell disease

急诊科静脉输液复苏与镰状细胞病成人患者的肾脏结局

Carden, Marcus A; Lebensburger, Jeffrey; Rosamond, Wayne; Tanabe, Paula; Derebail, Vimal K

Multicenter comparative study of polysomnography outcomes in children with the monogenic disorder sickle cell disease

一项针对患有单基因疾病镰状细胞病的儿童的多中心比较研究,旨在比较多导睡眠图检查结果。

Alishlash, Ammar Saadoon; Nourani, Anis Rabbani; Lebensburger, Jeffrey; Rothman, Jennifer A; Ali-Dinar, Tarig; Ezmigna, Dima

Biomarkers to Differentiate Acute Chest Syndrome From Vaso-Occlusive Crisis in Children With Sickle Cell Disease.

用于区分镰状细胞病患儿急性胸痛综合征和血管阻塞危象的生物标志物

Wang Karen, Olave Nelida, Aggarwal Saurabh, Oh Joo-Yeun, Patel Rakesh P, Rahman A K M Fazlur, Lebensburger Jeffrey, Alishlash Ammar Saadoon

Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study

羟基脲预防镰状细胞病患儿脑损伤(HU Prevent)——一项随机、安慰剂对照的II期可行性/试点研究

Casella, James F; Furstenau, Dana K; Adams, Robert J; Brambilla, Donald J; Lebensburger, Jeffrey D; Fehr, James J; Jordan, Lori C; King, Allison A; Ichord, Rebecca N; McKinstry, Robert C; Kraut, Michael A; Shaw, Dennis W; White, Desiree A; Whyte-Stewart, Donna A; Avadhani, Radhika; Barron-Casella, Emily A; Cannon, Alicia D; Eaton, Cyd K; Riekert, Kristin A; Shay, Joanne E; Smith-Seidel, Cynthia A; Weiss, Diane C; Ostapkovich, Noeleen D; Vermillion, Krista; Treine, Kevin E; Kingsbury, Claire E; Strouse, John J; Thompson, Richard E; Hanley, Daniel F

Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia

可溶性尿激酶型纤溶酶原激活物受体与肾脏疾病及其在镰状细胞贫血中的进展相关

Zahr, Rima S; Rashkin, Sara R; Ruiz, Maria Armila; Elsherif, Laila; Ren, Guohui; Salas, Guadalupe; Ataga, Kenneth I; Gordeuk, Victor R; Lebensburger, Jeffrey; Zhang, Xu; Saraf, Santosh L

Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease

镰状细胞病成人患者新发和复发性梗死的发生率和危险因素

Jordan, Lori C; King, Allison A; Kanter, Julie; Lebensburger, Jeff; Ford, Andria L; Varughese, Taniya E; Garrett, Lisa; Mullis, Lauren; Saint Jean, LeShana; Davis, Samantha; Dumas, Jeanine; Kassim, Adetola A; Rodeghier, Mark; Hikima, Mustapha S; Suwaid, Mohammad A; Saleh, Mohammed K; DeBaun, Michael R